Penetration of etoposide into human malignant brain tumors after intravenous and oral administration (original) (raw)
References
Carney DN, Grogan L, Smit EF, Harford P, Berendsen HH, Postmus PE (1990) Single-agent oral etoposide for elderly small cell lung cancer patients. Semin Oncol 17:49 Google Scholar
Creaven PJ (1982) The clinical pharmacology of VM 26 and VP 16-213. A brief overview. Cancer Chemother Pharmacol 7:133 Google Scholar
D'Incalci M, Sessa C, Rosso C, Roviaro G, Mangioni C (1985) Pharmacokinetics of etoposide in gestochoriocarcinoma. Cancer Treat Rep 69:69 Google Scholar
Feun LG, Lee Y-Y, Yung W-KA, Savaraj N, Qallace S (1987) Intracarotid VP-16 in malignant brain tumors. J Neurooncol 4:397 Google Scholar
Finn GP, Bozek T, Souhami RL, Slevin ML, Thomas DGT (1985) High-dose ctoposide in the treatment of relapsed primary brain tumors. Cancer Treat Rep 69:603 Google Scholar
Giannone L, Wolff SN (1987) Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation. Cancer Treat Rep 71:759 Google Scholar
Haaxma-Reiche H, Berendsen HH, Postmus PE (1988) Podophyllotoxins for brain metastases of small cell lung cancer. J Neurooncol 6:231 Google Scholar
Hainsworth JD, Johnson DH, Frazier SR, Greco FA (1989) Chronic daily administration of oral etoposide. A phase I trial. J Clin Oncol 7:396 Google Scholar
Hande KR, Wedlund PJ, Noone RM, Wilkinson GR, Greco FA, Wolff SN (1984) Pharmacokinetics of high-dose etoposide (VP-16-213) administration to cancer patients. Cancer Res 44:379 Google Scholar
Holthuis JJM, Postmus PE, Oort WJV, Hulshoff B, Verleun H, Sleijfer DT, Mulder NH (1986) Pharmacokinetics of high dose etoposide (VP16-213). Eur J Cancer Oncol 22:1149 Google Scholar
Idzu G, Yazawa Y, Tachibana M, Terada T, Hashimoto Y, Shimazu T (1989) Determination of etoposide in plasma by high performance liquid chromatography with fluorescence detection. Clin Rep 23:479 Google Scholar
Kleisbauer JPP, Lena-Nosny N, Vesco D (1987) Taux seriques dans le liquide cephalo-rachidien apres forte dose d'etopside administree par voie intraveineuse. Bull Cancer 74:631 Google Scholar
Kleisbauer JP, Vesco D, Orehek J, Blaive B, Clary C, Poirier R, Saretto S, Carles P, Dongay G, Guerin JC, Martinat Y (1988) Treatment of brain metastases of lung cancer with high doses of etoposide (VP16-213). Cooperative study of the Groupe Français Pneumo Cancérologie. Eur J Cancer Oncol 24:131 Google Scholar
Kobayashi T, Yoshida J, Ishiyama J, Noda S, Kito A, Kida Y (1989) Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study. J Neurosurg 70:676 Google Scholar
Lee SJ, Murphy WK, Glisson BS, Dhinga HM, Holoye PY, Hong WK (1989) Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol 7:916 Google Scholar
Lu K, Savraj N, Feun L, Leaven M, Loo TL (1982) Clinical pharmacology and intracerebral tumor penetration of 4′-demethyl epipodophyllotoxin 9-(4,6-_O_-ethylidene-β-d-glucopyranoside) (VP-16, NSC-141 540). Clin Pharmacol Ther 31:245 Google Scholar
Postmus PE, Holthuis JJM, Haaxma-Reiche H, Mulder NH, Vencken LM, Oort WJ, Sleijfer DT, Sluiter HJ (1984) Penetration of VP16-213 into cerebrospinal fluid after high-dose intravenous administration. J Clin Oncol 2:215 Google Scholar
Postmus PE, Haaxma-Reiche H, Sleijfer DT, Kirkpatriek A, McVie JG, Kleisbauer JP, for the EORTC Lung Cooperative Group (1989) High dose etoposide for brain metastasis of small cell lung cancer. A phase II study. Br J Cancer 59:254 Google Scholar
Slevin ML (1991) The clinical pharmacology of etoposide. Cancer 67:319 Google Scholar
Stewart DJ, Richard M, Hugenholtz H, Dennery J (1983) VP-16 (VP) and VM-26 (VM) penetration into human brain tumors (BT). Proc Am Assoc Cancer Res 24:133 Google Scholar
Stewart DJ, Richard M, Hugenholtz H, Dennery JM, Belanger R, Gerin-Lajoie J, Montpetit V, Nundy D, Prior J, Hopkins HS (1984) Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors. J Neurooncol 2:133 Google Scholar
Takeda S, Takada S, Kojima T, Kinoshita K, Sakamoto S (1990) Oral etoposide therapy in stage III–IV ovarian carcinoma. J Jpn Soc Cancer Ther 25:2562 Google Scholar
Tirelli U, D'Incalci M, Canetta R, Tumolo S, Franchin G, Veronesi A, Galligiono E, Trovo MG, Rossi C, Grigoletto E (1984) Etoposide (VP-16-213) in malignant brain tumors: a phase II study. J Clin Oncol 2:432 Google Scholar
Viens P, Lagrange J-L, Thyss A, Ayela P Frenay M, Schneider M (1988) Brain metastases of lung cancer: excessive toxicity of high dose VP 16213. Eur J Cancer Clin Oncol 24:1905 Google Scholar
Yuki K, Kodama Y, Emoto K, Yukawa O, Onda J, Uozumi T (1989) A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide. Jpn J Cancer Chemother 16:2651 Google Scholar